Results INTRA PROTOCOL ANALYSIS
|
|
- Gwen Howard
- 6 years ago
- Views:
Transcription
1 Results INTRA PROTOCOL ANALYSIS
2 BCVA logmar Pre op Post op 6m Post op 1y /30 9/10 18/5 30/3 TE p=0.13 p=0.4 p=0.14 p=0.96 p=0.51 BCVA improved in all groups, but this improvement was not statistically significant from baseline
3 Spherical equivalent /30 9/10 18/5 30/3 TE p=0.57 p=0.14 p=0.17 Pre op Post op 6m Post op 1y p=0.67 p=0.44 SE decreased in all groups, but this decrease was not statistically significant from baseline
4 Thinnest pachymetry /30 9/10 18/5 30/3 TE Pre op Post op 6m Post op 1y P <0.01 P< 0.01 p=0.21 p= 0.5 p=0.31 Thinnest pachymetry reduced in all groups and the change from baseline to 1 year was statistically significant only in Group 1 and 2
5 Flat Keratometry /30 9/10 18/5 30/3 TE Pre op Post op 6m Post op 1y p=0.29 p=0.35 p=0.78 p=0.88 p=0.85 K1 flattened in all groups, but this flattening from baseline to 1 year was not statistically significant
6 Steep Keratometry /30 9/10 18/5 30/3 TE Pre op Post op 6m Post op 1y P = 0.25 p=0.49 p=0.76 p=0.88 p=0.73 K2 flattened in all groups, but this flattening was not statistically different from baseline to 1 year
7 Endothelial count /30 9/10 18/5 30/3 TE Pre op Post op 6m Post op 1y p=0.04 p=0.04 p=0.054 p=0.01 p=0.01 Endothelial count decreased in all groups, but this reduction was not statistically significant from baseline
8 Corneal densitometry Pre op Post op 6m Post op 1y 0 3 for 30 9 for for 5 30 for 3 TE p < 0.05 p = 0.01 p = 0.14 p = 0.02 p = 0.74 Change in Corneal densitometry was statistically different from baseline only in 3 for 30 (CXL) and 9 for 10 mins (ACXL) group.
9 Cornea.2013 May;32(5): Clinical Ophthalmology 2014: Transient haze was noted in 71% of the accelerated CXL cases and in 91% of the conventional CXL ACXL shows comparable results with conventional CXL in arresting the progression of KC
10 20% DEXTRAN (Vibex TM ) Polyglucose biopolymers Abundant hydrophilic hydroxyl groups---- >High affinity for water Viscosity---- > maintains a film of riboflavin to act as a reservoir during the soak. Dehydrate and thin the cornea Draws water out of cornea Slows diffusion of riboflavin Extended soak time 0.85% HPMC (Hydroxyl Propyl MethylCellulose) (Vibex Rapid TM, Vibex TM ) Alternative to dextran Water soluble viscoelastic polymer Faster diffusion of riboflavin. The diffusivity of a 0.1% riboflavin and HPMC formulation (VibeX Rapid) is twice that of a 0.1% riboflavin formulation containing dextran (VibeX). The length of time required to reach a steady state concentration in the corneal stroma is reduced by half.
11 BENZALKONIUM CHLORIDE {BAC} (Paracel, Mediocross TE) Enhances epithelial-permeability Opens the epithelial tight junctions Impact of BAK - duration and concentration dependent. Once the epithelial junctions have been sufficiently loosened, 0.25% riboflavin and saline may be used for rest of the procedure This reduces the duration of epithelial exposure to BAK. SALINE (Vibex Xtra TM ) Riboflavin 0.25% with NaCl TEKXL 1 st formulation - breach the corneal epithelium. ParaCel, a dextran-free, hypo-osmolar, 0.25% riboflavin 5 -phosphate containing epithelial-permeability enhancing agents including BAK 2 nd formulation - of 0.25% riboflavin and saline without permeability enhancers
12 Introduction Corneal collagen cross-linking (CXL) halts progression of keratoconus Accelerated cross linking (ACXL) aims To reduce patient discomfort To achieve more effective time management To avoid the excessive corneal dehydration and thinning Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 2006; 17: Accelerated versus conventional corneal collagen cross-linking in the treatment of mild keratoconus: a comparative study. Clinical Ophthalmology 2014:
13 Riboflavin solutions MEDIO CROSS D 0.1% riboflavin solution with 20% Dextran (isotonic) 3,0ml: the standard solution for CXL. Epi-off 20min soak MedioCross TE CE TransEpithelial Solution MedioCross M 0.1% riboflavin solution with 1.1% HPMC Without Dextran MedioCross H Hypotonic Riboflavin Solution For Corneal Swelling (Thin corneas) MedioCross L 0.23% Riboflavin solution for LASIK and PRK
14 Transepithelial Riboflavin formulation Ricrolin TE (Sooft,Italy) Transepithelial Crosslinking Riboflavin Formulations Formulation composition 0.1% riboflavin-5-phosphate, 15% dextran T500, sodium edetate, trometamol, and NaCl UVA delivery device UV-X 1000, IROC Innocross, Switzerland Iontophoresis N/A Medio-cross (Peschke Meditrade GmbH, Germany) 0.25% riboflavin-5-phosphate hydroxypropyl methylcellulose, benzalkonium chloride, NaCl UV-X 1000, IROC Innocross, Switzerland N/A ParaCel (Avedor Inc, USA) Ricrolin+ (Sooft,Italy) VibeX Xtra (Avedro Inc, USA) 0.25% riboflavin-5-phosphate, hydroxypropyl methylcellulose, sodium edetate, trometamol, benzalkonium chloride, NaCL 0.1% riboflavin-5-phosphate, sodium edetate, trometamol, sodium dihydrogen phosphate dihydrate, and sodium phosphate dibasic dehydrate KXL, Avedro Inc., USA KXL, Avedro Inc., USA N/A I-ON CXL generator (Sooft, Italy) 0.25% riboflavin-5-phosphate and NaCl KXL, Avedro Inc., USA N/A
15 Transepithelial Crosslinking Comparing protocols Impact of various transepithelial protocols on corneal epithelium in regard to pain and epithelial integrity in the early postoperative period has been studied* *Taneri S, Oehler S, Lytle G, Dick HB, Evaluation of epithelial integrity with various transepithelial corneal cross-linking protocols for treatment of keratoconus. J Ophthalmol. 2014;2014: doi: /2014/ Epub 2014 Aug 12.
16 *Taneri S, Oehler S, Lytle G, Dick HB, Evaluation of epithelial integrity with various transepithelial corneal cross-linking protocols for treatment of keratoconus. J Ophthalmology 2014;2014: doi: /2014/ Incidence of pain & Epithelial defect post TECXL Percentage of eyes with postoperative pain following transepithelial CXL Percentage of eyes with postoperative epithelial defect following transepithelial CXL
17 Practices during Soak and Irradiation Effect of Speculum Comparing protocol alterations* to the standard Dresden protocol Group1 Group 3 A standard CXL Group 2 Received hypotonic treatment 20% dextran Lid speculum removed during with led to a significant reduction in corneal pachymetry the 30 minutes of saturation riboflavin without isotonic riboflavin in with isotonic riboflavin. Closed eyelids during the riboflavin saturation phase significantly dextran 20% dextran reduced the number of eyes requiring swelling before irradiation. Need for the development of new riboflavin solutions with isooncotic 15% properties loss of corneal Pachymetry Pachymetry thickness after 30 increased by 1% increased by 11% minutes during the after 30 minutes saturation phase 90% needed swelling with hypoosmolar Riboflavin Only 13% needed swelling None required swelling with Riboflavain * Schmidinger G, Pachala M, Prager F. Pachymetry changes during corneal crosslinking: Effect of closed eyelids and hypotonic riboflavin solution. J Cataract Refract Surg 2013; 39:
18 Different Protocols Epithelium Riboflavin concentration Off 0.1% with 20% Dextran (conventional) Riboflavin impregnation Every 2 mins for 30 min, then every 5 min during fluence UV-A fluence (365nm) Irradiation time Total energy 3 mw/cm 2 30mins 5.4 J/cm 2 Off 0.1% with 20% Dextran (ACXL) Every 2 min for 20 mins 30mW/cm 2 3mins 5.4 J/cm 2 Off 0.1% with 20% Dextran (ACXL) Every 2 mins for 20 mins, then every 2 mins during fluence 18 mw/cm 2 5mins 5.4 J/cm 2 Off 0.1% with 20% Dextran (ACXL) On 0.25% with HPMC, NaCl, EDTA, Benzalkonium Chloride (TECXL) Off 0.5% with 0.9% NaCl (Hypoosmolar for corneal thickness <400 microns) Every 2 mins for 20 mins, then once after 5 mins Every 2 mins for 30 mins Every 3 mins for 30 mins, then every 20 secs for 5 mins 9 mw/cm 2 10mins 5.4 J/cm 2 45 mw/cm 2 2mins 40secs 7.2J.cm 2 3 mw/cm 2 30mins 5.4 J/cm 2
19 Transepithelial Riboflavin formulation Formulation composition UVA delivery device Iontophoresis Ricrolin TE (Sooft,Italy).1% riboflavin-5-phosphate, 15% dextran T500, sodium edetate, trometamol, and NaCl UV-X 1000, IROC Innocross, Switzerland N/A Medio-cross (Peschke Meditrade GmbH, Germany) 0.25% riboflavin-5-phosphate hydroxypropyl methylcellulose, benzalkonium chloride, NaCl UV-X 1000, IROC Innocross, Switzerland N/A ParaCel (Avedor Inc, USA) Ricrolin+ (Sooft,Italy) VibeX Xtra (Avedro Inc, USA) 0.25% riboflavin-5-phosphate, hydroxypropyl methylcellulose, sodium edetate, trometamol, benzalkonium chloride, NaCL 0.1% riboflavin-5-phosphate, sodium edetate, trometamol, sodium dihydrogen phosphate dihydrate, and sodium phosphate dibasic dehydrate KXL, Avedro Inc., USA KXL, Avedro Inc., USA 0.25% riboflavin-5-phosphate and NaCl KXL, Avedro Inc., USA N/A I-ON CXL generator (Sooft, Italy) N/A
20 Cutan Ocul Toxicol 2014 Jun;33(2): Resolution of transient changes in Endothelial cell density indicate safe recovery
21 PURPOSE: To study potential damage to ocular tissue during CXL by means of the riboflavin/uva (370 nm) approach. RESULTS : Damage thresholds for keratocytes and endothelial cells are 0.45 and 0.35 mw/cm 2, respectively. In a 400-μm-thick cornea, the irradiance at endothelial level was 0.18 mw/cm 2 CONCLUSIONS : After CXL, repopulation of keratocytes in 300 μm depth takes up to 6 months. As long as the cornea treated has a minimum thickness of 400 μm, the corneal endothelium, lens & retina will not experience damage. The light source - homogenous irradiance, avoiding hot spots. Cornea 2007;26:
22 Riboflavin Solutions Standard Riboflavin Solution with Dextran for epi-off procedure (3ml) The Dresden Original:Time proven Riboflavin solution with dextran Recommended instillation time: 20 minutes (1 drop every 2 minutes = 10 drops) Ingredients: 0.1 % Riboflavin (Vitamin B2), 20 % dextran 500 Standard Riboflavin Solution without Dextran for epi-off procedure (3ml) Does not reduce corneal thickness Recommended instillation time: 20 minutes (1 drop every 2 minutes = 10 drops) Ingredients: 0.1 % Riboflavin (Vitamin B2), 1.1 % HPMC Transepithelial Solution for epi-on procedure (2ml) Recommended instillation time: 20 minutes (1 drop every 2 minutes = 10 drops) Pre-loaded glass syringe containing 2.0 ml liquid Ingredients: 0.25 % Riboflavin (Vitamin B2), 1.2 % HPMC, 0.01 % Benzalkoniumchloride
23 Riboflavin Solutions Hypotonic Riboflavin Solution for corneal swelling (1.5ml) To swell thin corneas (< 400 μ) by means of osmotic effect Recommended instillation time: 1 drop every 5 seconds until corneal thickness has reached 400 μ Ingredients: 0.1 % Riboflavin (Vitamin B2) Riboflavin Solution for use with LASIK procedures on thin corneas (1.95ml) Recommended usage: after flap preparation and excimer treatment Put 3 5 drops on stroma, put flap back, wait 3 4 minutes, open flap Rinse off Riboflavin, put flap back and radiate with 1/2 of the recommended energy (1/2 of the time) Ingredients: > 0.23 % Riboflavin (Vitamin B2)
24 Corneal Cross linking with Isotonic solution* Hypotonic riboflavin 0.1 % solution) Begin dropping PESCHKE isotonic solution: 1 drop every 2 minutes for 20 minutes (= 10 drops). After 20 minutes - check at slit lamp with blue light whether anterior chamber is slightly yellow. If not, continue to drop isotonic solution until anterior chamber is yellow. If thinnest spot is under 400 μm without epithelium, apply hypotonic solution (using a 24 G cannula) to swell cornea. 1 drop every 5 seconds until corneal thickness isat least 400 μm. UV-illumination treatment set to 18 mw/cm2 for 5 min, focus distance between beam aperture and eye ~ 45 mm 55 mm and adjust beam diameter Post-op check-ups: 1 day 3 days 1 week 1 month 3 months 6 months yearly intervals. *Peschke Isotonic solution treatment information, Peschke trade GmbH.
25 Percentage of eyes with postoperative pain following transepithelial CXL Percentage of eyes with postoperative epithelial defect following transepithelial CXL Incidence of pain & Epithelial defect post TECXL
26 TOPOGRAPHY GUIDED PRK (TPRK) CENTERED CONE DECENTERED CONE
Riboflavin, Oxygen and Light. Sabine Kling, PhD, Farhad Hafezi, MD,PhD
Riboflavin, Oxygen and Light Sabine Kling, PhD, Farhad Hafezi, MD,PhD Corneal Cross-linking Increasing corneal stiffness to stop the progression of keratoconus 365 nm, 3mW/cm 2 30 min UV-light de-epithelialization
More informationEfficacy of transepithelial corneal cross-linking using iontophoresis
Efficacy of transepithelial corneal cross-linking using iontophoresis Experimental studies on eye-bank donor eyes and Preliminary results on the clinical trial NCT02117999 Marco Lombardo, MD, PhD Senior
More informationML-00043B FULL PRESCRIBING INFORMATION: CONTENTS*
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PHOTREXA VISCOUS and PHOTREXA safely and effectively. See full prescribing information for PHOTREXA
More informationProf.Paolo Vinciguerra, M.D. 1, 2 Riccardo Vinciguerra, M.D Humanitas University 1. Humanitas Clinical and Research Center IRCS 2
Prof.Paolo Vinciguerra, M.D. 1, 2 Riccardo Vinciguerra, M.D. 1-3 1 Humanitas University 1 Humanitas Clinical and Research Center IRCS 2 Columbus, Ohio State University 3 University of Insubria, Varese
More informationCorneal Cross-Linking in Keratoconus Using the Standard and Rapid Treatment Protocol: Differences in Demarcation Line and 12-Month Outcomes METHODS
Cornea Corneal Cross-Linking in Keratoconus Using the Standard and Rapid Treatment Protocol: Differences in Demarcation Line and 12-Month Outcomes Sara Brittingham, Christoph Tappeiner, and Beatrice E.
More informationPhotrexa Viscous, Photrexa and the KXL System for Corneal Cross-Linking
Photrexa Viscous, Photrexa and the KXL System for Corneal Cross-Linking First and Only FDA Approved Therapeutic treatment for progressive keratoconus and corneal ectasia following refractive surgery The
More informationArticle. Reference. Collagen crosslinking with ultraviolet-a and hypoosmolar riboflavin solution in thin corneas. HAFEZI, Farhad, et al.
Article Collagen crosslinking with ultraviolet-a and hypoosmolar riboflavin solution in thin corneas HAFEZI, Farhad, et al. Abstract Corneal collagen crosslinking (CXL) with riboflavin and ultraviolet-a
More informationPRELIMINARY RESULTS IN TRANS EPITHELIAL CORNEAL CROSSLINKING
PRELIMINARY RESULTS IN TRANS EPITHELIAL CORNEAL CROSSLINKING Authors: Diana Mihu, Adriana Stănilă, Mihaela Florescu, ValericaProştean Ophthalmology Clinic Sibiu Ocular Surface Research Center Sibiu, 2
More informationTRANSEPITHELIAL CORNEAL CROSS-LINKING BY IONTOPHORESIS
TRANSEPITHELIAL CORNEAL CROSS-LINKING BY IONTOPHORESIS FOR THE OPHTHALMOLOGIST Guidelines for transepithelial cross-linking (absorption through IONTOPHORESIS) INGREDIENTS 100 ml contain (mg/100 ml): Riboflavin
More informationTRANSEPITHELIAL CORNEAL CROSS-LINKING BY IONTOPHORESIS
TRANSEPITHELIAL CORNEAL CROSS-LINKING BY IONTOPHORESIS FOR THE PATIENT IL CROSS-LINKING TRANSEPITHELIAL CORNEALE TRANSEPITELAILE CROSS-LINKING BY MEDIANTE IONTOPHORESIS IONTOFORESI WHAT IS TRANSEPITHELIAL
More informationSimultaneous Topography-guided Surface Ablation with Collagen Cross-linking for Keratoconus
IJKECD Case series Simultaneous Topography-guided Surface Ablation with Collagen 10.5005/jp-journals-10025-1124 Cross-linking for Keratoconus Simultaneous Topography-guided Surface Ablation with Collagen
More informationCorneal collagen crosslinking for keratoconus or corneal ectasia without epithelial debridement
(2015) 29, 764 768 2015 Macmillan Publishers Limited All rights reserved 0950-222X/15 www.nature.com/eye CLINICAL STUDY Corneal collagen crosslinking for keratoconus or corneal ectasia without epithelial
More informationTransepithelial cross-linking
Transepithelial cross-linking Collection of scientific studies PROCEDURE FOR TRANSEPITHELIAL CROSS-LINKING (TE-CXL) Instill one drop of pilocarpine 2% 30 minutes before UV-A treatment. Place the patient
More informationLong-term Results of Cross-linking in Children with Keratoconus
Long-term Results of Cross-linking in Children with Keratoconus Beatrice Frueh,MD Professor of Ophthalmology Financial Disclosure No finantial interests 8-year-old Progression in 6 months Keratoplasty
More informationCorneal Crosslinking Without Epithelial Removal
1 Corneal Crosslinking Without Epithelial Removal R. Doyle Stulting, MD, PhD 1 Jonathan Woolfson, MD 1 Bill Trattler, MD 2 Roy Rubinfeld, MD, MA 3 1 Woolfson Eye Institute, Atlanta, GA 2 Center for Excellence
More informationFirst and Only FDA Approved. Keratoconus and Corneal Cross-Linking. Information for Referring Physicians
Keratoconus and Corneal Cross-Linking Information for Referring Physicians First and Only FDA Approved Therapeutic treatment for progressive keratoconus and corneal ectasia following refractive surgery
More informationOur experience with Athens protocol - simultaneous topo-guided photorefractive keratectomy followed by corneal collagen cross linking for keratoconus
International Journal of Research in Medical Sciences Shah S et al. Int J Res Med Sci. 2016 Jul;4(7):2639-2644 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20161924
More informationAT A GLANCE EPI-ON VERSUS EPI-OFF: WHERE DO WE STAND? Strides have been made in epi-on techniques, but more are needed.
EPI-ON VERSUS EPI-OFF: WHERE DO WE STAND? Strides have been made in epi-on techniques, but more are needed. Epi-on techniques are still considered less efficacious BY COSIMO MAZZOTTA, MD, PhD The technique
More informationEpi-on Iontophoresis CXL latest clinical data Prof Paolo Vinciguerra
Epi-on Iontophoresis CXL latest clinical data Prof Paolo Vinciguerra Associate Professor Ophthalmology Department of Biomedical Sciences, Humanitas University Director Eye Centre, Humanitas Clinical and
More informationThirty-month results after the treatment of post-lasik ectasia with allogenic lenticule addition and corneal cross-linking: a case report
Li et al. BMC Ophthalmology (2018) 18:294 https://doi.org/10.1186/s12886-018-0967-z CASE REPORT Open Access Thirty-month results after the treatment of post-lasik ectasia with allogenic lenticule addition
More informationEfficacy and safety of transepithelial collagen cross linking for progressive keratoconus
Open Access Original Article Efficacy and safety of transepithelial collagen cross linking for progressive keratoconus Sameer Shahid Ameen 1, Mohammad Asim Mehboob 2, Kashif Ali 3 ABSTRACT Objective: To
More informationCase Report Outcome of Two Corneal Collagen Crosslinking Methods in Bullous Keratopathy due to Fuchs Endothelial Dystrophy
Case Reports in Medicine, Article ID 463905, 5 pages http://dx.doi.org/10.1155/2014/463905 Case Report Outcome of Two Corneal Collagen Crosslinking Methods in Bullous Keratopathy due to Fuchs Endothelial
More informationTransepithelial cross-linking
Transepithelial cross-linking Collection of scientific studies November 29 th, 211 - UPDATE PROCEDURE FOR TRANSEPITHELIAL CROSS-LINKING (TE-CXL) Instill one drop of pilocarpine 2% 3 minutes before UV-A
More informationPOST-LASIK ECTASIA MANAGEMENT
POST-LASIK ECTASIA MANAGEMENT A. John Kanellopoulos MD 1,2 1: Laservision.gr Clinical & Research Eye Institute, Athens, Greece 2: NYU Medical School Department of Ophthalmology, NY, NY Financial interests:
More informationSimultaneous Topography-Guided PRK with CXL Versus CXL Alone in Kconus: Prospective Comparative Study
This paper was conferred with the AIOS CORNEA AWARD for the BEST PAPER of CORNEA Sessions. This paper was also judged the BEST PAPER of CORNEA - II Session. Simultaneous Topography-Guided PRK with CXL
More informationTitle: Two-photon fluorescence microscopy of corneal riboflavin absorption
Title: Two-photon fluorescence microscopy of corneal riboflavin absorption through an intact epithelium. Authors: Daniel M Gore FRCOphth, 1* Paul French PhD, 2 David O Brart MD FRCS, 3 Chris Dunsby PhD,
More informationPreliminary Results of UV-A Riboflavin Crosslinking in Progressive Cases of Keratoconus, in Pakistani Population
Original Article Preliminary Results of UV-A Riboflavin Crosslinking in Progressive Cases of Keratoconus, in Pakistani Population Muhammad Dawood Khan, Sameer Shahid Ameen, Omar Ishtiaq, Muhammad Khizar
More informationTopo-Guided Custom Ablation (TGCA) and Corneal Collagen Cross-Linking (CCL) in treatment of advanced keratoectasia
Topo-Guided Custom Ablation (TGCA) and Corneal Collagen Cross-Linking (CCL) in treatment of advanced keratoectasia Alekandar Stojanovic, MD University Hospital North Norway Tromsø, Norway Jia Zhang, MD
More informationEpithelium On Versus Epithelium Off
ONLINE SURVEY Point/Counterpoint: Epithelium On Versus Epithelium Off Surgeons discuss whether to remove the outer corneal layer during CXL. By Parag A. Majmudar, MD; Rebecca McQuaid, MSc; Arthur B. Cummings,
More informationManagement of Unpredictable Post-PRK Corneal Ectasia with Intacs Implantation
Management of Unpredictable Post-PRK Corneal Ectasia with Intacs Implantation Mohammad Naser Hashemian, MD 1 Mahdi AliZadeh, MD 2 Hassan Hashemi, MD 1,3 Firoozeh Rahimi, MD 4 Abstract Purpose: To present
More informationPhotochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia
Photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia Issued: September 2013 guidance.nice.org.uk/ipg466 NICE has accredited the process used
More informationCorneal collagen cross-linking (CXL), using the original. Transepithelial Riboflavin Absorption in an Ex Vivo Rabbit Corneal Model.
Cornea Transepithelial Riboflavin Absorption in an Ex Vivo Rabbit Corneal Model Daniel M. Gore, 1 David O Brart, 2 Paul French, 3 Chris Dunsby, 3,4 and Bruce D. Allan 1 1 Moorfields Eye Hospital, London,
More informationInterventional procedures guidance Published: 25 September 2013 nice.org.uk/guidance/ipg466
Photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia Interventional procedures guidance Published: 25 September 2013 nice.org.uk/guidance/ipg466
More informationTitle: Transepithelial riboflavin absorption in an ex-vivo rabbit corneal model.
1 Title: Transepithelial riboflavin absorption in an ex-vivo rabbit corneal model. 2 3 4 Authors: Daniel M Gore FRCOphth, 1* David O Brart MD FRCS, 2 Paul French PhD, 3 Chris Dunsby PhD, 3,4 Bruce D Allan
More informationKeratoconus is a noninflammatory process in which the
CLINICAL SCIENCE Epithelium-Off Corneal Collagen Cross-linking Versus Transepithelial Cross-linking for Pediatric Keratoconus Adriano Magli, MD,* Raimondo Forte, MD,* Achille Tortori, MD, Luigi Capasso,
More informationCorneal Remodeling. Medical Coverage Policy. Related Coverage Resources. Table of Contents. Coverage Policy. Corneal Crosslinking
Medical Coverage Policy Effective Date... 8/15/2018 Next Review Date... 8/15/2019 Coverage Policy Number... 0141 Corneal Remodeling Table of Contents Coverage Policy... 1 Overview... 3 General Background...
More informationCorneal haze is a condition resulting from several
CLINICAL SCIENCE Automated Detection and Classification of Corneal Haze Using Optical Coherence Tomography in Patients With Keratoconus After Cross-Linking Ahmad R. Dhaini, PhD,* Maamoun Abdul Fattah,
More informationPHOTOREFRACTIVE KERATECTOMY (PRK) PATIENT INFORMATION BOOKLET
616.365.5775 www.keillasik.com PHOTOREFRACTIVE KERATECTOMY (PRK) PATIENT INFORMATION BOOKLET Please read this entire booklet. Discuss its contents with your doctor so that questions are answered to your
More informationCORNEAL IONTOPHORESIS APPLIED TO CXL PROCEDURE
CORNEAL IONTOPHORESIS APPLIED TO CXL PROCEDURE IONTOPHORESIS IONTOPHORESIS(from iòntos=ion andphòresis= to moveacross, ionsmovingacross) consistsin the oneway movement of charged moleculesthroughoutthe
More informationAbdel Rahman ElSebaey, MD, PhD.
Surface Ablation Refractive Surgery Abdel Rahman ElSebaey, MD, PhD. Menoufia University History Correction of optical defects of human eye started 1200 AD. Spherical error corrected by spectacle on 13
More informationIn the early 1990s, photorefractive keratectomy (PRK) and
CLINICAL SCIENCE Collagen Crosslinking After Radial Keratotomy Uri Elbaz, MD, Sonia N. Yeung, MD, PhD, FRCSC, Setareh Ziai, MD, FRCSC, Alejandro D. Lichtinger, MD, Noa Avni Zauberman, MD, MHA, Yakov Goldich,
More informationNational Institute for Health and Clinical Excellence
National Institute for Health and Clinical Excellence [IP724/2] [Photochemical corneal cross linkage using riboflavin and ultraviolet A for keratoconus and keratectasia] Consultation table IPAC date: [Thursday
More informationRiboflavin/ultraviolet A corneal collagen cross-linking (CXL)
Cornea A Comparison of Different Corneal Iontophoresis Protocols for Promoting Transepithelial Riboflavin Penetration Daniel M. Gore, 1 David P. O Brart, 2 Paul French, 3 Chris Dunsby, 3,4 and Bruce D.
More informationConclusion- Autologous plasma is superior to conventional treatment for improving ocular surface health and subjective comfort
1 2 3 4 5 6 7 8 Anterior Segment Disease Therapy: A Look Into The Future Eric E. Schmidt, O.D. Omni Eye Specialists Wilmington, NC Autologous Serum The How More aptly called Eye-Platelet Rich Plasma (EPRP)
More informationSCHWIND CAM Perfect Planning wide range of applications
SCHWIND CAM Perfect Planning wide range of applications ORK-CAM PresbyMAX PTK-CAM 2 SCHWIND CAM the system solution The modular design of the SCHWIND CAM offers customised treatment planning for a uniquely
More informationCXL. The Road Ahead. Now that corneal cross-linking has received FDA approval, will clinical practice outpace evidence-based protocols?
CXL The Road Ahead Now that corneal cross-linking has received FDA approval, will clinical practice outpace evidence-based protocols? By Gabrielle Weiner, Contributing Writer For almost 20 years, researchers
More informationINFORMED CONSENT FOR CORNEAL COLLAGEN CROSS-LINKING WITH RIBOFLAVIN (C3-R) FOR PATIENTS WITH KERATOCONUS OR CORNEAL ECTASIA
INFORMED CONSENT FOR CORNEAL COLLAGEN CROSS-LINKING WITH RIBOFLAVIN (C3-R) FOR PATIENTS WITH KERATOCONUS OR CORNEAL ECTASIA INTRODUCTION: This information is to help you make an informed decision about
More informationSimultaneous Conventional Photorefractive Keratectomy and Corneal Collagen Cross-linking for Pellucid Marginal Corneal Degeneration
ORIGINAL ARTICLE Simultaneous Conventional Photorefractive Keratectomy and Corneal Collagen Cross-linking for Pellucid Marginal Corneal Degeneration George D. Kymionis, MD, PhD; Michael A. Grentzelos,
More informationPardon the Objection: Cases Marc R. Bloomenstein OD, FAAO Scot Morris, OD Derek Cunningham, OD Kathy Mastrota, OD
I. Introduction a. Treating the anterior segment different for each patient b. How can new technology help your patients? c. The anterior segment is going to be the hot bed for new technology II. Lipiflow
More informationIntrastromal corneal ring
Intrastromal corneal ring Kyriakidou Nantia M.D. Diathlasis Day Care Unit Scienti1ic Workshop of Diathlasis Day Care Unit 18-19 November, 2016 The Met Hotel Thessaloniki, Greece DAY CARE UNIT DIATHLASIS,
More informationTransepithelial Corneal Cross-linking Using an Enhanced Riboflavin Solution
ORIGINAL ARTICLE Transepithelial Corneal Cross-linking Using an Enhanced Riboflavin Solution Zisis Gatzioufas, MD, PhD; Frederik Raiskup, MD, PhD, FEBO; David O Brart, FRCS, FRCOphth, MD; Eberhard Spoerl,
More informationClinical experience of 9,000 small aperture Inlays for presbyopia correction
Clinical experience of 9,000 small aperture Inlays for presbyopia correction Minoru Tomita, MD, PhD Shinagawa LASIK Center, Tokyo, Japan September 7 th, 2012, ISOP meeting in Tokyo, JAPAN 1,060,666 Femto
More informationADVANCED OPTOMETRIC PROCEDURES
ADVANCED OPTOMETRIC PROCEDURES Disclosures Dr. Nathan Lighthizer, OD, FAAO Dr. Aaron McNulty, OD, FAAO Course Outline Allergy testing Corneal collagen crosslinking Intense pulsed light therapy Epithelial
More informationGrand Rounds CASE CONSULTATION. Edited by Alfredo Castillo, MD & Jaime Aramberri, MD
CASE CONSULTATION Grand Rounds Edited by Alfredo Castillo, MD & Jaime Aramberri, MD A 23-year-old patient with a stable myopia for 3 years attended for refractive surgery assessment. Corrected visual acuity
More informationThis is an Open Access document downloaded from ORCA, Cardiff University's institutional repository:
This is an Open Access document downloaded from ORCA, Cardiff University's institutional repository: http://orca.cf.ac.uk/44020/ This is the author s version of a work that was submitted to / accepted
More informationCOLLAGEN CROSSLINKING FOR KERATOCONUS CAN CHANGE SCLERAL SHAPE Gregory DeNaeyer OD 1 and Donald R Sanders MD, PhD 2
COLLAGEN CROSSLINKING FOR KERATOCONUS CAN CHANGE SCLERAL SHAPE Gregory DeNaeyer OD 1 and Donald R Sanders MD, PhD 2 1 Optometrist at Arena Eye Surgeons 2 Director, Center for Clinical Research and President
More informationKeratoconus Clinic. Optometric Co-management Opportunities
Keratoconus Clinic Optometric Co-management Opportunities The Bochner Eye Institute established the first Keratoconus Clinic in Canada in 2008. The consultation and advanced imaging are OHIP covered. All
More informationNEW VISION EYE CENTER
Topographic Aberrometric Guided PRK For Keratoconus With Accelerated Corneal Cross-Linking Using Schwind AMARIS 750S Laser NEW VISION EYE CENTER Dr. Safwan Al Bayati FRCS (Glasgow) FICMS OPTH Consultant
More informationInterpretation of corneal tomography
Interpretation of corneal tomography Presented by Chameen Samarawickrama - Westmead Hospital - Liverpool Hospital - University of Sydney - University of New South Wales The University of Sydney Page 1
More informationEffects of Intracorneal Ring Segment on Corneal Biomechanics in Keratoconic Eyes. Abstract
Effects of Intracorneal Ring Segment on Corneal Biomechanics in Keratoconic Eyes Javad Amoozadeh, MD 1 Nima Mirzaee Rad, MD 2 Amir Houshang Beheshtnejad, MD 3 Ahmad Kheirkhah, MD 1 Hassan Hashemi, MD 4,5
More informationCollagen Cross-linking for the Treatment of Keratoconus in Pediatric Patients
Rana Hanna et al Review Article 10.5005/jp-journals-10025-1106 Collagen Cross-linking for the Treatment of Keratoconus in Pediatric Patients 1 Rana Hanna, 2 Eran Berkwitz, 3 Jamyl Habib Castillo, 4 Beatrice
More informationViΤAL Keratoconus Classification, The AMART (or SECRET) & Gregory Lens Projects
ViΤAL Keratoconus Classification, The AMART (or SECRET) & Gregory Lens Projects Anastasios Charonis MD PhD Medical Director, AthensVision Eye Institute anastasioscharonis@athensvision.com Purpose: To
More informationEquivalence of Biomechanical Changes Induced by Rapid and Standard Corneal Cross-linking, Using Riboflavin and Ultraviolet Radiation METHODS
Cornea Equivalence of Biomechanical Changes Induced by Rapid and Standard Corneal Cross-linking, Using Riboflavin and Ultraviolet Radiation Silvia Schumacher, Lydia Oeftiger, and Michael Mrochen PURPOSE.
More informationCorneal Collagen Crosslinking for Post-LASIK Ectasia: An Australian Study. 18 rigid gas permeable contact lenses, and intrastromal corneal
original clinical study Corneal Collagen Crosslinking for ost-lasik Ectasia: An Australian Study Jessica Y. Tong, BMed, MD,* Deepa Viswanathan, hd, FRCS,* Christopher Hodge, hd, BAppSc(Orth), Gerard Sutton,
More informationPhotorefractive Keratectomy as A Retreatment of Residual Myopia after Previous Laser in Situ Keratomileusis
Photorefractive Keratectomy as A Retreatment of Residual Myopia after Previous Laser in Situ Keratomileusis Alireza Ashtari, MD 1 Hassan Razmju, MD 2 Amin Masjedi, MD 3 Alireza Zandi, MD 1 Mehdi Tavakoli,
More informationDistinction layer by layer. HRT II Rostock Cornea Module
Distinction layer by layer HRT II Rostock Cornea Module Homogenously illuminated, undistorted images Movie capture Manual Pachymetry Epithelial and intra-corneal pachymetry Full corneal thickness Post-LASIK
More informationInformed Consent for Excimer Laser Surface Ablation Surgery (PRK, LASEK, epi-lasik, and others)
Informed Consent for Excimer Laser Surface Ablation Surgery (PRK, LASEK, epi-lasik, and others) Patient name (printed): Patient date of birth: Please review this information so you can make an informed
More informationLaser-assisted in situ keratomileusis (LASIK) is the most
CLINICAL SCIENCE Visual Outcomes After SMILE, LASEK, and LASEK Combined With Corneal Collagen Cross-Linking for High Myopic Correction Sangyoon Hyun, MD,* Seongjun Lee, MD, and Jae-hyung Kim, MD* Purpose:
More informationOcular Jeopardy Marc R. Bloomenstein OD, FAAO
I. Introduction a. Introduction of topics b. Various ocular related topics II. Lipiflow a. Meibomian gland dysfunction i. Define the disease ii. Prevalence iii. Current treatment options 1. Lid scrubs
More informationComparison of analgesic effect of preoperative topical Diclofenac versus Ketorolac on postoperative pain after Corneal Collagen Cross Linkage
Open Access Original Article Comparison of analgesic effect of preoperative topical Diclofenac versus Ketorolac on postoperative pain after Corneal Collagen Cross Linkage Murtaza Sameen 1, Muhammad Saim
More informationMedical Affairs Policy
Medical Affairs Policy Service: Corneal Treatments and Specialized Contact Lenses (Corneal remodeling, Corneal transplant, Corneal collagen crosslinking, Intrastromal Rings- INTACS, Keratoconus treatments,
More informationSynergEyes PS Practitioner Training
SynergEyes PS Practitioner Training Post-Surgical Market For 30 years, visual scientists from around the world have struggled with the challenge of surgically correcting human refractive error. While great
More information~ 1 ~ CLINIQUE LASERVUE. Informed Consent Form for LASIK
~ 1 ~ CLINIQUE LASERVUE Informed Consent Form for LASIK Please read the following information and consent form very carefully. Your initials indicate that you understand all of the necessary patient information
More informationOcular Studies of EMF Exposure at the MMW M. Kojima 1,2,3), Y. Suzuki 4)
Ocular Studies of EMF Exposure at the MMW M. Kojima 1,2,3), Y. Suzuki 4) 1. Division of Vision Research for Environmental Health, Medical Research Institute, Kanazawa Medical University 2. Department of
More informationSCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM
Page 1 of 5 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM FML Liquifilm Sterile Eye Suspension COMPOSITION FML Liquifilm Sterile Eye Suspension contains: Fluorometholone 1,0 mg/ml Liquifilm
More informationSubject Index. Atopic keratoconjunctivitis (AKC) management 16 overview 15
Subject Index Acanthamoeba keratitis, see Infective keratitis Acute allergic conjunctivitis AKC, see Atopic keratoconjunctivitis Allergy acute allergic conjunctivitis 15 atopic keratoconjunctivitis 15
More informationIn Practice. Surgical Procedures Diagnosis New Drugs
In Practice Surgical Procedures Diagnosis New Drugs 32 35 Bowman + Bulk = Better Results Mid-stromal lamellar keratoplasty (MSLK) offers a new approach to the management of advanced keratoconus that can
More informationCollagen Cross-Linking Using Riboflavin and Ultraviolet-A for Corneal Thinning Disorders: An Evidence-Based Analysis
Collagen Cross-Linking Using Riboflavin and Ultraviolet-A for Corneal Thinning Disorders: An Evidence-Based Analysis G Pron, L Ieraci, K Kaulback, Medical Advisory Secretariat, Health Quality Ontario November
More informationL. Spadea, R. Ferrante, F. Romani, A. Di Gregorio
University of L Aquila Eye Clinic Head: Prof. Leopoldo Spadea ULTRAFAST EXCIMER LASER FOR TRANS-EPITHELIAL CUSTOMIZED PHOTOREFRACTIVE SURGERIES: CLINICAL RESULTS WITH 6 MONTHS FOLLOW UP L. Spadea, R. Ferrante,
More informationSAFETY AND EFFICACY OF CORNEAL COLLAGEN CROSSLINKING WITH RIBOFLAVIN AND ULTRAVIOLET-A IN THE TREATMENT OF PROGRESSIVE KERATOCONUS
SAFETY AND EFFICACY OF CORNEAL COLLAGEN CROSSLINKING WITH RIBOFLAVIN AND ULTRAVIOLET-A IN THE TREATMENT OF PROGRESSIVE KERATOCONUS DISSERTATION SUBMITTED FOR MS (Branch III) Ophthalmology THE TAMILNADU
More informationTransepithelial corneal collagen crosslinking: Bilateral study
ARTICLE Transepithelial corneal collagen crosslinking: Bilateral study Massimo Filippello, MD, PhD, Edoardo Stagni, MD, David O Brart, MD, FRCS, FRCOphth PURPOSE: To evaluate the efficacy of transepithelial
More informationCover Page. Author: Parker, Jack Title: Recent innovations in minimally invasive anterior and posterior lamellar keratoplasty Issue Date:
Cover Page The handle http://hdl.handle.net/1887/50484 holds various files of this Leiden University dissertation Author: Parker, Jack Title: Recent innovations in minimally invasive anterior and posterior
More informationCorneal collagen cross-linking (CXL) is used to increase
REVIEW ARTICLE Corneal Collagen Cross-linking: A Review of Clinical Applications Kunyong Xu, MD, MHSc,*Þ Tommy C.Y. Chan, FRCS,þ Rasik B. Vajpayee, MS, FRCSEd, FRANZCO, and Vishal Jhanji, MDþ ** Corneal
More informationCorneal molding and riboflavin-uva collagen cross-linking in keratoconus
Corneal molding and riboflavin-uva collagen cross-linking in keratoconus Antonio Calossi Department of Optics and Optometry, University of Turin, Italy Studio Optometrico Calossi, Certaldo (Florence),
More informationContoura TM Vision Correction
Contoura TM Vision Correction Fernando Faria Correia, Financial Disclosures: Alcon/Wavelight Cairo (Egypt) 26/01/2018 Topography-guided ablations Topography guided ablations Evolution from complicated
More informationHun Lee 1,2, David Sung Yong Kang 3, Byoung Jin Ha 3, Jin Young Choi 3, Eung Kweon Kim 2,4, Kyoung Yul Seo 2 and Tae-im Kim 2*
Lee et al. BMC Ophthalmology (2016) 16:139 DOI 10.1186/s12886-016-0320-3 RESEARCH ARTICLE Open Access Changes in posterior corneal elevations after combined transepithelial photorefractive keratectomy
More informationKeratocyte cytotoxicity of riboflavin/uvatreatment
(2004) 18, 718 722 & 2004 Nature Publishing Group All rights reserved 0950-222X/04 $30.00 www.nature.com/eye LABORATORY STUDY 1 Department of Ophthalmology Technical University of Dresden Dresden, Germany
More informationAnterior segment imaging
CET CONTINUING Sponsored by 1 CET POINT Anterior segment imaging Sundeep Vaswani, BSc (Hons), MCOptom 39 The anterior segment of the eye encompasses all structures from the front surface of the cornea
More informationThe pinnacle of refractive performance.
The pinnacle of refractive performance. WaveLight REFRACTIVE PORTFOLIO Advancing REFRACTIVE SURGERY Contoura Vision sets a new standard in LASIK outcomes More than 98% of patients would choose it again.
More informationCorneal Hydrops Secondary to Intrastromal Corneal Ring Intrusion into the Anterior Chamber 7 Years after Implantation: A Case Report
Ophthalmol Ther (2017) 6:373 379 DOI 10.1007/s40123-017-0105-7 CASE REPORT Corneal Hydrops Secondary to Intrastromal Corneal Ring Intrusion into the Anterior Chamber 7 Years after Implantation: A Case
More informationBiomechanical Weakening of Different Re-treatment Options After Small Incision Lenticule Extraction (SMILE)
Biomechanical Weakening of Different Re-treatment Options After Small Incision Lenticule Extraction (SMILE) Sabine Kling, PhD; Bogdan Spiru, MD; Farhad Hafezi, MD, PhD; Walter Sekundo, MD, PhD ABSTRACT
More informationPearls for the Refractive Technician Fadiah Alkhawaldeh, IMBA, COT, ROUB
Pearls for the Refractive Technician Fadiah Alkhawaldeh, IMBA, COT, ROUB Cleveland Clinic Cole Eye Institute OOS, Columbus, OH February, 2014 alkhawf@ccf.org NO FINANCIAL DISCLOSURES A Puzzle of an Eye
More informationThe Effect of Standard and High-Fluence Corneal Cross- Linking (CXL) on Cornea and Limbus
Cornea The Effect of Standard and High-Fluence Corneal Cross- Linking (CXL) on Cornea and Limbus Olivier Richoz, 1 David Tabibian, 1 Arthur Hammer, 1 François Majo, 2 Michael Nicolas, 2 and Farhad Hafezi
More informationCorporate Presentation NASDAQ: EYEG
Corporate Presentation NASDAQ: EYEG Forward Looking Statements Some of the matters discussed in this presentation contain forward-looking statements that involve significant risks and uncertainties, including
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION Contents METHODS... 2 Inclusion and exclusion criteria... 2 Supplementary table S1... 2 Assessment of abnormal ocular signs and symptoms... 3 Supplementary table S2... 3 Ocular
More informationCataract Surgery in the Patient with a History of LASIK or PRK
Cataract Surgery in the Patient with a History of LASIK or PRK #56996-RS April 2018 Sebastian Lesniak, MD Matossian Eye Associates None Disclosures Bio Matossian Eye Associates, Hopewell NJ, 7/2015 Present
More informationNEW CHONDROITIN (CS 2%) HYALURONATE (HA 2%) EXCELLENT ANTERIOR CHAMBER STABILITY, LUBRICATING PROPERTIES & EFFICIENT REMOVAL
High-Performing Viscoelastic VISCO DISPERSIVE NEW CHONDROITIN (CS 2%) HYALURONATE (HA 2%) DESCRIPTION : IXIUM HCS is a visco-elastic high molecular weight solution of a non-inflammatory, highly purified
More informationCombined ethanol-assisted and blunt mechanical corneal epithelial peeling technique
TECHNICAL REPORT Combined ethanol-assisted and blunt mechanical corneal epithelial peeling technique Rafael Bilbao-Calabuig, MD 1 ; Félix González-López, MD 1 ; José R. Villada-Casaponsa, MD 1 ABSTRACT:
More informationResearch Progress on Corneal Collagen Cross-Linking for Corneal Ulcerative Keratitis
International Journal of Ophthalmology & Visual Science 2018; 3(2): 21-26 http://www.sciencepublishinggroup.com/j/ijovs doi: 10.11648/j.ijovs.20180302.12 ISSN: 2637-384X (Print); ISSN: 2637-3858 (Online)
More informationEvaluation of the Efficacy of Excimer Laser Ablation of Cross-Linked Porcine Cornea
Evaluation of the Efficacy of Excimer Laser Ablation of Cross-Linked Porcine Cornea Shihao Chen 1, Yini Li 1, Aleksander Stojanovic 2, Jia Zhang 1, Yibo Wang 1, Qinmei Wang 1 *, Theo Seiler 3 1 The Affiliated
More information